$0.00 $0.00 (0.0%)

12:00 AM EST on 01/01/01

Biocoral (NASDAQOTH:BCRA)

CAPS Rating: No stars

Current Price $0.00 Mkt Cap $0.00
Open $0.00 P/E Ratio 0.00
Prev. Close $0.00 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume
52-Wk Range $0.00 - $0.00 Avg. Daily Vol.

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

2 Outperform
10 Underperform
 

All-Star Players

0 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTH:BCRA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

LarryRicardo (99.95)
Submitted March 26, 2009

First off, thanks to TMFSmashy for a great blog a few weeks ago. I forgot how it got on my watchlist, so I accidentally did a bit of homework. Here are some highlights:Its auditors recently resigned: http://biz.yahoo.com/e/090126/bcra.ob8-k.html And,… More

NASDAQOTH:BCRA VS S&P 500 (SPY)

Fools bullish on NASDAQOTH:BCRA are also bullish on:

Fools bearish on NASDAQOTH:BCRA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about BCRA.

Recs

0
Member Avatar spundun (25.92) Submitted: 11/23/2009 5:37:54 PM : Underperform Start Price: $32.00 NASDAQ OTHER:BCRA Score: +297.88

tsif smashy

Recs

0
Member Avatar SirCharms (< 20) Submitted: 6/10/2009 5:40:17 PM : Underperform Start Price: $38.00 NASDAQ OTHER:BCRA Score: +338.92

I could be misreading things here, but from their 10-K, it sure looks like this is a company valued at $438M that is doing several $100K worth of business. Let's see if there's a good reason:
"In addition, where our reliance on an outside manufacturer to produce our autologous fibrin glue resulted in the failure of this product, we have now commenced a lawsuit against this manufacturer [for 110M Euro]"
In short, their entire market cap is devoted to a big lawsuit and trying to redeploy a (single) medical product that was defective the first time around. I'm not saying it won't happen, just that I like my odds here.

Recs

3
Member Avatar LarryRicardo (99.95) Submitted: 3/26/2009 1:03:50 AM : Underperform Start Price: $38.00 NASDAQ OTHER:BCRA Score: +338.92

First off, thanks to TMFSmashy for a great blog a few weeks ago. I forgot how it got on my watchlist, so I accidentally did a bit of homework. Here are some highlights:

Its auditors recently resigned: http://biz.yahoo.com/e/090126/bcra.ob8-k.html

And, that auditor had the following comments in its own 2005 audit: "The inspection team identified matters that it considered to be audit deficiencies. The deficiencies identified in both of the audits reviewed included deficiencies of such significance that it appeared to the inspection team that the Firm did not obtain sufficient competent evidential matter to support its opinion on the issuer's financial statements. Those deficiencies included the failure to perform and document, in both of the audits reviewed, an evaluation as to whether there was substantial doubt regarding the ability of the issuer to continue as a going concern."

http://www.pcaobus.org/Inspections/Public_Reports/2005/Moore_and_Associates_Chartered.pdf

The good news is they recently found a new auditor:

http://biz.yahoo.com/e/090217/bcra.ob8-k.html

But, the bad news is this auditor seems to be worse than the last one. Here's an excerpt from the auditors own 2006 audit: "The inspection team identified matters that it considered to be audit deficiencies. The deficiencies identified in two of the audits reviewed included deficiencies of such significance that it appeared to the inspection team that the Firm did not obtain sufficient competent evidential matter to support its opinion on the issuer's financial statements. Those deficiencies included –
(1) the failure to perform and document sufficient audit procedures related to the valuation of intangible assets;
(2) the failure to perform and document sufficient audit procedures related to the valuation of certain equity transactions;
(3) the failure to perform and document an appropriate evaluation of an issuer's ability to continue as a going concern; and
(4) the failure to perform and document sufficient audit procedures related to cash balances.

And of course, the stock itself hasn't traded since January. I'll let readers review the financial statements themselves. But they are pretty unbelievable, given the market cap. I wouldn't be surprised if the next trade is down 80%, which would make it unplayable in Caps. That would be a shame...

Leaderboard

Find the members with the highest scoring picks in BCRA.

Score Leader

SirCharms

SirCharms (< 20) Score: +338.92

The Score Leader is the player with the highest score across all their picks in BCRA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
smithtz 82.19 7/30/2009 Underperform NS $38.00 -99.72% +239.20% +338.92 0 Comment
examinebeyond 30.40 7/30/2009 Underperform 5Y $38.00 -99.72% +239.20% +338.92 0 Comment
seanchile 47.01 7/30/2009 8/23/2010 Underperform 3Y $38.00 -99.72% +239.20% +338.92 0 Comment
LarryRicardo 99.95 7/30/2009 Underperform 3Y $38.00 -99.72% +239.20% +338.92 1 Comment
SirCharms < 20 7/30/2009 Underperform 5Y $38.00 -99.72% +239.20% +338.92 1 Comment
nebcornhusker13 94.62 11/6/2009 Underperform 3Y $32.00 -99.67% +210.25% +309.92 0 Comment
chinneymartin 48.27 11/9/2009 Underperform 3W $32.00 -99.67% +206.14% +305.81 0 Comment
MisterCHW 99.92 5/20/2010 Underperform 5Y $15.00 -99.29% +202.14% +301.43 0 Comment
stockjock11 55.09 6/14/2010 Underperform 5Y $15.00 -99.29% +199.02% +298.31 0 Comment
spundun 25.92 11/25/2009 Underperform 5Y $32.00 -99.67% +198.21% +297.88 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BCRA.